| Issue |
BIO Web Conf.
Volume 229, 2026
The 3rd International Conference of Advanced Veterinary Science and Technologies for Sustainable Development (3rd ICAVESS 2025)
|
|
|---|---|---|
| Article Number | 01004 | |
| Number of page(s) | 7 | |
| Section | Advancing Animal Health | |
| DOI | https://doi.org/10.1051/bioconf/202622901004 | |
| Published online | 12 March 2026 | |
A Case Report of Feline Cholangiohepatitis: Clinical Presentation and Diagnostic Work-Up
1 Clinical Clerkship Student, Faculty of Veterinary Medicine, Universitas Gadjah Mada, Yogyakarta, Indonesia
2 Departement of Internal Medicine, Faculty of Veterinary Medicine, Universitas Gadjah Mada, Yogyakarta, Indonesia
3 Prof. Soeparwi Veterinary Teaching Hospital, Faculty of Veterinary Medicine, Universitas Gadjah Mada, Yogyakarta, Indonesia
* Corresponding author: This email address is being protected from spambots. You need JavaScript enabled to view it.
Abstract
An 8-year-old male Maine Coon cat weighing 4.1 kgs presented with jaundice and constipation for over one week. The chief complaint included lethargy, anorexia, and reduced water intake. A veterinarian had previously administered glycerin and bisacodyl enemas, but complete evacuation of the stool was not achieved. Hematological and serum biochemical analyses revealed non-regenerative anemia, lymphocytopenia, neutrophilia, and eosinopenia. Liver function tests showed elevated alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), gamma-glutamyl transferase (GGT), total bilirubin, bile acids, and amylase levels. Abdominal ultrasonography demonstrated a markedly enlarged gallbladder with a thickened wall and a slightly hyperechoic intraluminal mass suggestive of sludge. Furthermore, dilatation of the hepatic artery and portal vein was observed, consistent with hepatic inflammation. Based on the clinical presentation, hematological and biochemical profiles, and ultrasonographic findings, cholangiohepatitis was diagnosed with a guarded to poor prognosis (dubia ad infausta). Intravenous fluid therapy, a hepatic-support diet, and hepatoprotective medication were all part of the therapeutic strategy to promote liver function. Close observation of liver enzyme levels and the patient’s reaction to treatment will be crucial in addition to these measures. This case report presents the diagnostic work-up to feline cholangiohepatitis identified through the clinical manifestation of jaundice.
© The Authors, published by EDP Sciences, 2026
This is an Open Access article distributed under the terms of the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.

